Global Metformin Hydrochloride Market 2016 by Manufacturers, Share, Sales, Revenue, Price and Forecast to 2021

metformin-hydrochloride-market

Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.

Access Full Report: http://www.fiormarkets.com/report/global-metformin-hydrochloride-market-by-manufacturers-regions-type-14501.html

Scope of the Report:
This report focuses on the Metformin Hydrochloride in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers
Bristol-Mayers Squibb
Shouguang Fukang Pharmaceutical
Harman Finochem
Vistin Pharma
CR Double-Crane
Keyuan Pharmaceutical
FARMHISPANIA GROUP
Shijiazhuang Polee Pharmaceutical
Merck Sante
Aarti Drugs
TEVA
Taj API
Wanbury

Request For Sample Report: http://www.fiormarkets.com/report-detail/14501/request-sample

Market Segment by Regions
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type
Metformin HCL
Metformin DC

Market Segment by Applications
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others form

There are 13 Chapters to deeply display the global Metformin Hydrochloride market report.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com

banner